Rite Aid has filed for bankruptcy for a second time as it seeks a buyer. Rite Aid filed for Chapter 1 in U.S. Bankruptcy Court for the District of New Jersey to pursue a sale of its prescriptions, pharmacy and front-end inventory, and other assets, the company said.
Strategies first used during the pandemic are now being deployed for virtual nursing and hospital to home programs, says Scott Wilson, AVP of HHS enterprise care solutions at Teladoc.
HCA Florida JFK North Hospital in Palm Beach is expanding its Interventional Services Department, adding diagnostic cardiology to its offerings. Along with the new diagnostic cardiology capabilities, the department will now feature interventional radiology, vascular surgery and interventional oncology under one roof.
Davies Awardee Dr. Robert Jarve and his team at Corewell Health led an initiative to understand the top 5% of the Medicaid population that drives clinic utilization.
Nineteen states and Washington D.C. have filed a lawsuit seeking to block the Trump administration’s restructuring of the Department of Health and Human Services, claiming the federal government’s push to reshape the agency is “unconstitutional and illegal.”
Combining machine learning with video technology, along with AI automation, can improve both outcomes and surgical insights, say Transform Health Partners’ Dr. Peter Billing and Medtronic’s George Murgatroyd.
President Trump has signed an executive order to speed domestic manufacturing of prescription drugs.
Democratic senators and representatives have introduced companion resolutions calling on the Trump administration to reverse course on a decision to no longer require public input on changes to public programs and policies overseen by the Department of Health and Human Services.
President Donald Trump released a 2026 proposed budget on Friday that would cut $33.3 billion in discretionary funding for the Department of Health and Human Services, a 26.2% reduction from 2025. A proposed $674 million would be cut from the Centers for Medicare and Medicaid Program Management.
Cigna’s Evernorth is signaling that it will expand its GLP-1 medication offerings through the creation of a new program called Evernorth EnReachRx, a new patient support model for pharmacies that want to provide enhanced clinical services alongside the GLP-1 drugs.